Geode Capital Management’s BioRestorative Therapies BRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BRTX
Geode Capital Management's BRTX Position: Q3 2026 in Review
Geode Capital Management sold out of BioRestorative Therapies (BRTX) in Q3 2026, closing a stake of 7,621 shares — an estimated $57.3K sold.
Geode Capital Management first reported a position in BRTX in Q1 2022 and held it in 18 quarters. The position peaked at $193K in Q2 2023. 14 funds tracked by Wall St. Rank hold BRTX as of Q3 2026.
- Geode Capital Management reported no remaining BioRestorative Therapies position as of Q3 2026 after selling out during the quarter.
- Geode Capital Management sold 7,621 BioRestorative Therapies shares in Q3 2026, an estimated $57.3K.
- Geode Capital Management first reported a position in BioRestorative Therapies in Q1 2022 and held it in 18 quarters.
- Geode Capital Management's BioRestorative Therapies position peaked at $193K in Q2 2023.
- 14 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.